3,551 research outputs found
Stephane Mallarme: A synthesis of romanticism and parnassianism, 1970
No full textThe purpose of this paper is to analyse works of Stephane Mallarme, father of Symbolism, pointing out romantic and parnassian elements. Symbolism, like Romanticism, attempted to express the interior thoughts of man. The symbolist movement then, was not only a revolt against Parnassianism but also a return to Romanticism. On the other hand, one would not be incorrect in saying that Romanticism reached its culmination in the works of the symbolists poets. For this reason, an attempt will be made to show that the works of Mallarme, father of Symbolism, can be considered as a synthesis of Romanticism and Parnassianism. This thesis contains three chapters. The first chapter is devoted to a discussion of Romanticism and of Parnassianism. Special attention is given to the origin, development, characteristics and influences of each school. The relationship of one School with the other is also pointed out. The second chapter consists of a biographical sketch of Stephane Mallarme. Special emphasis is placed on factors and events in his life which may have influenced or determined the elements of Romanticism and Parnassianism in his poetry. The third chapter is devoted to an analysis of some of the poems of Stephane Mallarme", "Les Fenetres," V Apparition," "L'Azur," "Toast Funebre," "Le Vierge," "L'Apres-Midi d'un Faune." In these analyses special attention is given to the romantic and parnassian tendencies of the poems. Since these romantic-parnaassian elements occur frequently throughout his works, it has been concluded that Mallarme's poetry can be considered as a synthesis of the two poetic schools
Obama's visit to Korea : an unwavering US-ROC alliance amidst regional tensions
No full textFor more about the East-West Center, see http://www.eastwestcenter.org/Stephane Mot, Independent Author and Blogger living in Seoul, explains that "Obama's visit did not change the opinion of the vast majority of South Koreans who consider the US-ROK alliance to be unequal, but it did further confirm the importance of South Korea for US engagement towards Asia.
Response by Thuny et al. to Letter Regarding Article, “Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity”
No full textResponse to Letter Regarding Article : Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity by Marion Escudier, Jennifer Cautela, Nausicaa Malissen, Yann Ancedy, Morgane Orabona, Johan Pinto, Sandrine Monestier, Jean-Jacques Grob, Ugo Scemama, Alexis Jacquier, Nathalie Lalevee, Jeremie Barraud, Michael Peyrol, Marc Laine, Laurent Bonello, Franck Paganelli, Ariel Cohen, Fabrice Barlesi, Stephane Ederhy, and Franck Thuny.doi.org/10.1161/CIRCULATIONAHA.117.03057
Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications.
No full textLoss of cognitive function and hypertension are two common conditions in the elderly and both significantly contribute to loss of personal independency. Microvascular brain damage - the result of age-associated alteration in large arteries and the progressive mismatch of their cross-talk with small cerebral arteries - represents a potent risk factor for cognitive decline and for the onset of dementia in older individuals. The present review discusses the complexity of factors linking large artery to microvascular brain disease and to cognitive decline and the evidence for possible clinical markers useful for prevention of this phenomenon. The possibility of dementia prevention by cardiovascular risk factors control has not been demonstrated. In the absence of research clinical trials specifically and primarily designed to demonstrate the antihypertensive treatment efficacy for reducing the risk of dementia, further evidence demonstrating that it is possible to limit the progression of microvascular brain damage is needed
ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients
No full textHypertension is a major modifiable risk for the development of cardiovascular, cerebrovascular and renal diseases. Thus, effective treatment of high blood pressure is an important strategy for reducing disease burden; however, in spite of the availability of numerous effective therapies only 30-40 % of patients with hypertension achieve the recommended blood pressure goals of <140/90 mmHg. Lack of adherence to therapy and reluctance to intensify therapy are cited frequently to explain the discrepancy between potential and attained outcomes. Adherence is closely related to the tolerability, effectiveness and complexity of therapy. Therapeutic inertia may be influenced by concerns over tolerability, as well as the lack of clear preferences for therapies when managing patients with risk factors and comorbidities. Effective and well-tolerated single pill combination therapies are now available that improve adherence and simplify treatment. The combination of a renin-angiotensin system blocker with a calcium channel blocker and a diuretic improves adherence to therapy. We have devised a practical tool for orienting the application of well-tolerated single pill 2/3 drug fixed dose combination therapies in clinical situations commonly encountered when treating hypertensive patients. This approach employs the angiotensin receptor blocker olmesartan alone or in combinations with amlodipine and/or hydrochlorothiazide. This platform is based on clinical evidence, guidelines, best practice, and clinical experience where none of these is available. We believe it will increase the percentage of hypertensive patients who achieve blood pressure control when applied as part of an integrative approach that includes regular follow-up and instruction on lifestyle changes. © 2014 Springer International Publishing
Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications
No full textErratum to: ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients.
No full textHypertension is a major modifiable risk for the development of cardiovascular, cerebrovascular and renal diseases. Thus, effective treatment of high blood pressure is an important strategy for reducing disease burden; however, in spite of the availability of numerous effective therapies only 30-40 % of patients with hypertension achieve the recommended blood pressure goals of <140/90 mmHg. Lack of adherence to therapy and reluctance to intensify therapy are cited frequently to explain the discrepancy between potential and attained outcomes. Adherence is closely related to the tolerability, effectiveness and complexity of therapy. Therapeutic inertia may be influenced by concerns over tolerability, as well as the lack of clear preferences for therapies when managing patients with risk factors and comorbidities. Effective and well-tolerated single pill combination therapies are now available that improve adherence and simplify treatment. The combination of a renin-angiotensin system blocker with a calcium channel blocker and a diuretic improves adherence to therapy. We have devised a practical tool for orienting the application of well-tolerated single pill 2/3 drug fixed dose combination therapies in clinical situations commonly encountered when treating hypertensive patients. This approach employs the angiotensin receptor blocker olmesartan alone or in combinations with amlodipine and/or hydrochlorothiazide. This platform is based on clinical evidence, guidelines, best practice, and clinical experience where none of these is available. We believe it will increase the percentage of hypertensive patients who achieve blood pressure control when applied as part of an integrative approach that includes regular follow-up and instruction on lifestyle change
- …
